After an initial pregnancy resulted in a spontaneous loss in the first trimester, your patient is concerned about the possibility of this recurring. What is the chance of recurrence?
Which of the following is NOT an indication for genetic counseling?
What is a successful regimen for medical termination of pregnancy in the first trimester?
For Medical Termination of Pregnancy (MTP), whose consent should be obtained?
All of the following drugs are used in the medical termination of early pregnancy, EXCEPT:
Which of the following statements regarding medical abortion is true?
Fertilization of two ova discharged from the ovary at different times by two separate acts of coitus at short intervals can be termed as?
A 14-year-old victim of sexual assault with 22 weeks gestation has been brought for Medical Termination of Pregnancy (MTP). Which of the following statements is true?
How many medical practitioners' opinions are required for termination of pregnancy where gestational age exceeds 12 weeks but is within 20 weeks?
Explanation: ### Explanation **Correct Answer: B. Is no different than it was prior to the miscarriage** **1. Why Option B is Correct:** Spontaneous abortion (miscarriage) is a common event, occurring in approximately 10–15% of clinically recognized pregnancies. The vast majority (up to 50–70%) of isolated first-trimester losses are due to **sporadic chromosomal abnormalities** (e.g., autosomal trisomies), which are random events. Statistically, after a **single** spontaneous loss, the risk of a subsequent miscarriage remains approximately **15–20%**, which is essentially the same as the baseline risk for the general population. The risk only begins to rise significantly after two or more consecutive losses. **2. Why Other Options are Wrong:** * **Option A:** While the genetic makeup of the abortus explains *why* that specific pregnancy failed, it does not dictate the recurrence risk for the next pregnancy unless a parental balanced translocation is present (which is rare and not the default assumption after a single loss). * **Options C & D:** These options overestimate the risk. A 50% recurrence risk is not reached even after three consecutive losses. After two losses, the risk rises to ~25–30%, and after three, it reaches ~33–45%. **3. Clinical Pearls for NEET-PG:** * **Most common cause of first-trimester abortion:** Fetal genetic factors (Chromosomal anomalies). * **Most common specific chromosomal anomaly:** Autosomal Trisomy (Trisomy 16 is the most common specific trisomy). * **Recurrent Pregnancy Loss (RPL):** Defined by the ASRM as **two or more** failed clinical pregnancies. Investigations for RPL are generally not indicated after a single isolated loss. * **Prognosis:** Even after 3 losses, the most likely outcome for the next pregnancy is a live birth (approx. 60–70% success rate without intervention).
Explanation: ### Explanation **1. Why Option A is the correct answer:** In the context of standard obstetric guidelines (ACOG/RCOG), the primary trigger for genetic counseling regarding chromosomal abnormalities is **Advanced Maternal Age (AMA)**, defined as **≥35 years** at the time of delivery. While advanced paternal age (often cited as >40 or >45) is associated with a slight increase in *de novo* autosomal dominant mutations (e.g., Achondroplasia), it is **not** a standard, standalone indication for formal genetic counseling in the same way maternal age is. The term "Parental age" in Option A is a distractor because it generalizes both parents; specifically, paternal age alone does not mandate the same level of screening as maternal age. **2. Analysis of Incorrect Options:** * **B. Maternal age >35 years:** This is a classic indication. At age 35, the risk of a mid-trimester amniocentesis-related loss roughly equals the risk of Down Syndrome (1 in 270), making counseling and screening essential. * **C. Incest (Consanguinity):** Consanguineous unions significantly increase the risk of autosomal recessive disorders. Counseling is mandatory to discuss carrier screening and pedigree analysis. * **D. Previous child with dysmorphology:** Any previous offspring with structural defects, intellectual disability, or metabolic disorders requires genetic evaluation to determine the recurrence risk (e.g., translocation Down Syndrome vs. Trisomy 21). **3. NEET-PG High-Yield Pearls:** * **Advanced Maternal Age (AMA):** Defined as **≥35 years**. * **Most common chromosomal abnormality in AMA:** Trisomy 21 (Down Syndrome). * **Paternal Age Effect:** Associated with "Point Mutations" (e.g., Apert syndrome, Achondroplasia) rather than chromosomal non-disjunction. * **Indications for Prenatal Diagnosis:** Previous child with chromosomal anomaly, parental balanced translocation, ultrasound-detected fetal anomalies, and positive biochemical screening (Triple/Quadruple markers).
Explanation: The medical termination of pregnancy (MTP) in the first trimester (up to 10 weeks or 70 days of gestation) is most effectively achieved using a combination of **Mifepristone** and **Misoprostol**. ### **Explanation of the Correct Answer** The correct answer is **"All of the above"** because the regimen relies on the synergistic action of these drugs: * **Mifepristone (Option B) & RU486 (Option C):** These are the same drug. RU486 is the pharmacological designation for Mifepristone. It is an **anti-progestogen** that binds to progesterone receptors, leading to decidual necrosis, cervical softening, and sensitization of the uterus to prostaglandins. * **Misoprostol (Option A):** This is a **Prostaglandin E1 (PGE1) analogue**. It induces uterine contractions and cervical ripening, leading to the expulsion of the products of conception. ### **Why individual options are not "wrong" but incomplete:** While Mifepristone or Misoprostol can be used alone, their efficacy is significantly lower when used as monotherapy. The **WHO-recommended gold standard** is the combined regimen, which has a success rate of over 95-98%. Since RU486 and Mifepristone are synonyms, and both are used alongside Misoprostol, "All of the above" is the most accurate choice. ### **High-Yield Clinical Pearls for NEET-PG:** * **Standard Regimen:** 200 mg Mifepristone (oral) followed 24–48 hours later by 800 mcg Misoprostol (vaginal, buccal, or sublingual). * **MTP Act (India) Update:** Medical termination is legal up to **24 weeks** under specific conditions, but the medical (drug-based) regimen is most commonly used up to **9-10 weeks**. * **Side Effects:** The most common side effect of Misoprostol is diarrhea and shivering; the most common complication of MTP is incomplete abortion. * **Contraindications:** Suspected ectopic pregnancy, chronic adrenal failure, and long-term corticosteroid therapy.
Explanation: **Explanation:** In accordance with the **Medical Termination of Pregnancy (MTP) Act, 1971** (and its subsequent amendments), the decision to terminate a pregnancy rests solely with the pregnant woman. **1. Why the Correct Answer is Right:** The underlying medical and legal concept is **bodily autonomy**. Under the MTP Act, the only consent required for a major woman (above 18 years of age) or a woman who is not mentally ill is her own written consent. The law recognizes that the physical and psychological burden of pregnancy is borne by the woman; therefore, she has the final authority over her reproductive choices. **2. Why Incorrect Options are Wrong:** * **Options A & B:** Legally, the **consent of the husband or male partner is NOT required**. A doctor cannot be sued for performing an MTP without the husband's consent, provided the woman has consented. Requiring a partner's permission would violate the woman’s right to privacy and self-determination. * **Option D:** Informed consent is a mandatory legal and ethical prerequisite for any surgical or medical intervention. Performing an MTP without consent constitutes criminal assault and medical negligence. **3. High-Yield Clinical Pearls for NEET-PG:** * **Minors (<18 years) or Mentally Ill:** In these specific cases, written consent from the **guardian** is mandatory. * **Confidentiality:** The MTP Act mandates that the identity of the woman must be kept strictly confidential. * **Provider Requirement:** For MTP up to 12 weeks, the opinion of **one** Registered Medical Practitioner (RMP) is needed. From 12 to 20 weeks (and up to 24 weeks for specific categories), the opinion of **two** RMPs is required. * **Marital Status:** The 2021 Amendment now includes "unmarried women" under the clause for contraceptive failure, ensuring equal access to MTP regardless of marital status.
Explanation: ### Explanation The medical termination of pregnancy (MTP) involves the use of pharmacological agents to induce the evacuation of the products of conception. **Why Medroxyprogesterone is the Correct Answer:** **Medroxyprogesterone acetate (DMPA)** is a synthetic progestin used primarily as a **long-acting injectable contraceptive** or for treating conditions like endometriosis and abnormal uterine bleeding. In early pregnancy, progesterone is essential for maintaining the decidua and pregnancy viability. Therefore, a progestin like Medroxyprogesterone would theoretically support, rather than terminate, a pregnancy. **Analysis of Other Options:** * **Mifepristone (RU-486):** An anti-progestational agent that binds to progesterone receptors, leading to decidual breakdown, cervical softening, and increased uterine sensitivity to prostaglandins. It is the first-line drug for medical MTP. * **Misoprostol:** A PGE1 analogue that causes cervical ripening and potent uterine contractions to expel the products of conception. It is typically administered 24–48 hours after Mifepristone. * **Methotrexate:** A folate antagonist that inhibits DNA synthesis in rapidly dividing cells. It is used as a second-line agent for medical MTP (often in combination with Misoprostol) and is the drug of choice for the medical management of **unruptured ectopic pregnancy**. **High-Yield Clinical Pearls for NEET-PG:** * **MTP Act (India):** Medical termination is legal up to **24 weeks** under specific conditions. * **WHO Recommended Regimen (<9 weeks):** Mifepristone 200 mg orally followed by Misoprostol 800 mcg (vaginal/buccal/sublingual). * **Ectopic Pregnancy:** Methotrexate is indicated if the gestational sac is **<4 cm**, no fetal heart rate is present, and β-hCG is **<5000 mIU/mL**. * **Side Effects:** Misoprostol commonly causes diarrhea and shivering; Mifepristone can cause heavy bleeding.
Explanation: **Explanation:** **Correct Answer: A. It can be performed up to 9 weeks of gestation.** According to the latest guidelines under the **MTP (Amendment) Act 2021** and the Federation of Obstetric and Gynaecological Societies of India (FOGSI), medical abortion using the combination of Mifepristone and Misoprostol is approved for use up to **63 days (9 weeks)** of gestation. Previously, the limit was 7 weeks, but it has been extended based on clinical efficacy and safety data. **Analysis of Incorrect Options:** * **Option B:** Medical abortion cannot be administered by "any" RMP. It must be prescribed by a **Registered Medical Practitioner (RMP)** as defined under the MTP Act (someone with a recognized medical qualification and specific training/experience in Obstetrics and Gynecology). * **Option C:** Medical abortion is **not** exempted from the MTP Act. It must comply with all legal requirements, including documentation (Form I), maintenance of confidentiality, and being performed at a certified center (or by an RMP with access to a backup facility). * **Option D:** Medical abortion is a method of terminating an established pregnancy. It is **not** used for emergency contraception. Approved emergency contraceptives in India include Levonorgestrel (LNG) 1.5 mg or the Copper-T IUD. **High-Yield Clinical Pearls for NEET-PG:** * **Standard Regimen:** 200 mg Mifepristone (oral) followed by 400 mcg Misoprostol (oral/vaginal/buccal) after 24–48 hours. * **Mechanism:** Mifepristone is an anti-progestogen (detaches embryo); Misoprostol is a PGE1 analogue (induces contractions). * **MTP Act 2021:** Upper limit for abortion in special categories is 24 weeks; no limit for substantial fetal abnormalities (approved by a Medical Board).
Explanation: **Explanation:** **1. Why Superfecundation is Correct:** Superfecundation refers to the fertilization of two separate ova (released during the same menstrual cycle) by sperm from two different acts of coitus. If the acts of coitus involve different male partners, it is termed **heteropaternal superfecundation**, which can result in twins with different biological fathers. The key concept here is that the fertilization occurs within the **same ovulatory cycle**. **2. Analysis of Incorrect Options:** * **Superfoetation (Option B):** This is the fertilization of a second ovum when a fetus is already present in the uterus from a **previous cycle**. It involves the fertilization of two ova released in different menstrual cycles. This is extremely rare in humans because the high progesterone levels of pregnancy typically inhibit further ovulation and seal the cervix. * **Pseudocyesis (Option A):** Also known as "phantom pregnancy," this is a psychological condition where a non-pregnant woman exhibits physical symptoms of pregnancy (amenorrhea, abdominal enlargement, morning sickness) due to an intense desire or fear of being pregnant. * **Vanishing Twin Syndrome (Option D):** This occurs when one fetus in a multi-gestation pregnancy dies in utero and is subsequently reabsorbed by the mother or the other twin, often appearing as a "disappearance" on follow-up ultrasound. **3. NEET-PG High-Yield Pearls:** * **Superfecundation:** Same cycle, different coitus. * **Superfoetation:** Different cycles, different coitus (Rare/Theoretical in humans). * **Dizygotic Twins:** The physiological basis for superfecundation; it requires polyovulation. * **Legal Significance:** Heteropaternal superfecundation is a classic forensic/medico-legal scenario used to discuss disputed paternity in twins.
Explanation: ***MTP can be carried out up to 24 weeks*** - The **Medical Termination of Pregnancy (Amendment) Act, 2021**, allows termination of pregnancy up to **24 weeks** for certain vulnerable groups, including survivors of sexual assault and minors. - As a 14-year-old victim of sexual assault, she falls under the category which permits MTP up to 24 weeks. *One doctor is involved* - For pregnancies between 12 and 20 weeks, the opinion of **two registered medical practitioners** is required for MTP. - Beyond 20 weeks up to 24 weeks, as in this case, the opinion of **two registered medical practitioners** is also mandatory. *MTP done in 2nd trimester only when mother's life is in danger* - While danger to the mother's life is a valid reason for MTP, the **MTP Act 2021** has expanded the grounds for MTP in the second trimester (beyond 12 weeks) to include other categories like **sexual assault survivors** and **minors**, even if the mother's life is not immediately in danger. - The primary consideration here is the **vulnerability** of the pregnant person, not solely imminent danger to life. *MTP cannot be more than 20 weeks* - This statement is incorrect as per the **Medical Termination of Pregnancy (Amendment) Act, 2021**. - The Act raised the upper gestation limit from 20 to **24 weeks** for specific categories of women, including victims of sexual assault and minors, aligning with the current case.
Explanation: ***Two*** - According to the **Medical Termination of Pregnancy Act**, if the gestational age exceeds 12 weeks but is within 20 weeks, the opinion of **two registered medical practitioners** is required to perform an abortion. - This ensures a more robust review of the medical necessity and circumstances surrounding the decision to terminate a pregnancy at a later stage. *Four* - The requirement for four medical practitioners is not stipulated in the **Medical Termination of Pregnancy Act** for any gestational age. - Such a high number of opinions would create unnecessary logistical hurdles and delays for women seeking legal abortions. *Only one* - The opinion of only **one registered medical practitioner** is sufficient for terminations where the gestational age is up to **12 weeks**. - For gestational ages exceeding 12 weeks, the law mandates a more cautious approach, requiring additional medical consensus. *Three* - While multiple opinions are required for later-term abortions, the specific number mandated by the **Medical Termination of Pregnancy Act** for pregnancies between 12 and 20 weeks is two, not three. - The requirement shifts to a medical board for pregnancies exceeding **20 weeks** (and up to 24 weeks for specific categories of women), but this involves more than "three" individual opinions in a standard sense.
Ethical Principles in Reproductive Medicine
Practice Questions
Informed Consent in Obstetrics and Gynecology
Practice Questions
Ethical Issues in Assisted Reproduction
Practice Questions
Ethics of Prenatal Diagnosis and Intervention
Practice Questions
Maternal-Fetal Conflict
Practice Questions
Ethical Aspects of Contraception and Sterilization
Practice Questions
Abortion Ethics
Practice Questions
Research Ethics in Reproductive Medicine
Practice Questions
Ethics of Surrogacy and Third-Party Reproduction
Practice Questions
Reproductive Justice
Practice Questions
Get full access to all questions, explanations, and performance tracking.
Start For Free